[SOURCE] BLT 2025 Annual Report: Revenue of 1.852 Billion RMB, Dental Selective Laser Melting Pure Titanium Powder Obtains Class III Medical Device Registration Certificate [SOURCE] Bright Laser Tech…

Source: BLT 2025 Annual Report

DentalGoodNews｜On April 30, 2026, Xi'an BLT Additive Technology Co., Ltd. (hereinafter referred to as "BLT") released its 2025 annual report. The report shows that in 2025, the company achieved operating revenue of 1.852 billion yuan, a year-on-year increase of 39.69%; net profit attributable to shareholders of the parent company was 204 million yuan, a year-on-year increase of 95.14%. The company's non-recurring net profit attributable to shareholders of the parent company reached 150 million yuan in 2025, with a year-on-year increase of 319.37%. According to previous reports by DENTALGOODNEWS (Leading Dental Industry Media, DGN), BLT's net profit attributable to shareholders of the parent company in the first three quarters of 2025 increased by 234.83% year-on-year. The company stated that the rapid growth in full-year performance was mainly due to the expansion of production and operation scale, as well as the continuous development of new markets and application areas.

In the dental field, BLT's self-developed "Dental Laser Powder Bed Fusion Pure Titanium Powder" product has obtained a Class III Medical Device Registration Certificate approved by the National Medical Products Administration (NMPA). This powder product can be used in the manufacturing of medical devices such as dental implantation and restoration. The company believes that this event marks significant progress in the compliant application of BLT powder products in the medical field.

Source: BLT 2025 Annual Report

The financial report shows that the company continues to increase R&D investment. Total R&D investment in 2025 reached 242 million yuan, a year-on-year increase of 14.32%, accounting for 13.05% of operating revenue. In terms of production line automation, the company released the metal Additive Manufacturing (AM) BLT automated production line solution in 2025, which is expected to expand into the medical field.

Source: BLT 2025 Annual Report

By product category, in 2025, revenue from 3D Printing customized products and technical services was 1.052 billion yuan, a year-on-year increase of 52.63%, with a gross margin of 32.51%, down 0.65 percentage points from the previous year; revenue from 3D Printing equipment, accessories, and technical services was 686 million yuan, a year-on-year increase of 25.80%, with a gross margin of 44.67%, up 0.47 percentage points from the previous year; revenue from 3D Printing raw materials was 113 million yuan, a year-on-year increase of 24.80%, with a gross margin of 44.07%, up 14.85 percentage points from the previous year.

By industry segment, in 2025, revenue from the industrial sector was 894 million yuan, a significant year-on-year increase of 97.67%, with a gross margin of 30.16%, down 3.84 percentage points from the previous year; revenue from the aerospace sector was 883 million yuan, a year-on-year increase of 8.44%, with a gross margin of 45.22%, up 5.25 percentage points from the previous year; revenue from scientific research institutions was 66.4324 million yuan, a year-on-year increase of 20.25%; revenue from the medical sector was 4.7989 million yuan, a year-on-year increase of 40.10%, with a gross margin of 33.54%.

By region, the domestic market remains the mainstay, while overseas growth exceeded 100%. In 2025, domestic operating revenue was 1.690 billion yuan, a year-on-year increase of 35.75%, with a gross margin of 35.66%, down 0.57 percentage points from the previous year; overseas operating revenue was 162 million yuan, a year-on-year increase of 100.24%, with a gross margin of 59.17%, up 3.28 percentage points from the previous year.

Additionally, on December 31, 2025, BLT received a "Case Filing Notice" from the China Securities Regulatory Commission (CSRC) due to suspected violations of information disclosure laws and regulations, and was placed under investigation. The investigation is still ongoing. In July 2025, the company received a warning letter from the Shaanxi Securities Regulatory Bureau due to errors in information disclosure in its 2024 annual report and 2025 first-quarter report.

As of the end of 2025, the net assets attributable to shareholders of the parent company were 4.983 billion yuan, a year-on-year increase of 3.42%. The company plans to distribute a cash dividend of 0.82 yuan (tax included) per 10 shares to all shareholders.